Clinical Trials Directory

Trials / Unknown

UnknownNCT00778570

Advanced Surface Ablation (ASA) vs Laser-Assisted In Situ Keratomileusis (LASIK)

A Combined Retrospective and Prospective Chart Review Analysis of Visual Outcomes Following Excimer Laser Vision Correction

Status
Unknown
Phase
Study type
Observational
Enrollment
4,000 (estimated)
Sponsor
Ottawa Hospital Research Institute · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this combined retrospective and prospective chart review analysis is to investigate the safety, efficacy, and predictability obtained via Laser-Assisted In Situ Keratomileusis (LASIK) and Advanced Surface Ablation (ASA) over a wide range of refractive errors The working hypothesis is that there will be no difference in clinical outcomes between patients treated with LASIK or ASA.

Detailed description

Excimer laser vision correction (LVC) is a widely used procedure to correct nearsightedness, farsightedness, and astigmatism by reshaping the surface of the eye (cornea). Laser-Assisted In Situ Keratomileusis (LASIK) and Advanced Surface Ablation (ASA) and are techniques currently used to prepare the cornea for Excimer LVC. This review is intended to study whether LASIK is equal in visual outcome (null hypothesis), more effective (alternate hypothesis 1) or less effective (alternate hypothesis 2) than ASA in clinical outcome up to one year.

Conditions

Timeline

Start date
2007-02-01
Primary completion
2020-12-01
Completion
2020-12-01
First posted
2008-10-23
Last updated
2014-12-02

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00778570. Inclusion in this directory is not an endorsement.